Choose a language

About
About

We are a global, patient-led non-profit fighting for global healthcare equity in the diabetes access-to-medicines space.
- Our Values
- Our Team and Trustees
- Our Finances
- Our Ethical Fundraising Promise
What We Do
What We Do

We work to ensure that everyone with diabetes has dignity and that no one has to rely on unpredictable and unstable donations of insulin or diabetes supplies.
Global Network Network
Global Network

T1International Global Advocates, Chapters, and Advocacy Partners identify the issues in their country that they want to work on and develop action plans to make change.
- Global Map
Resources
Resources

Learn more about what we're fighting against and the world we are working to build together.
- Blog
- T1International in the News
Take Action
Take Action

Ready to take action in the fight for global healthcare equity? There are so many ways to get involved and support our work!
- Share Your Feedback
- Contact
Ways to Give
Ways to Give

Support T1International with a one-time gift, join our monthly giving circle, set up your estate for legacy giving, make an employer-matching gift, and more!
- Legacy Giving
- Employer Matching

Search for:

About
What We Do
Global Network
Resources
Take Action
Ways to Give
Donate

Donate

T1International in the News

Contact T1International’s press team

News and Statements from T1International

Read a sample of the coverage of our work from journalists and outlets around the world covering insulin access, drug pricing, and global health equity.

February 19, 2025

Miriam E. Tucker

Despite Price Caps, Some Still Struggle to Access Insulin (opens in a new tab)

February 15, 2023

Bram Sable-Smith

Armed with hashtags, these activists made insulin prices a presidential talking point (opens in a new tab)

July 21, 2022

Shaina Kasper and Aly Bancroft, Opinion Contributors

We are people with diabetes. Why is Congress suddenly leaving us behind? (opens in a new tab)

June 20, 2022

Jess Mador

High insulin prices have more people with diabetes sharing medicine and supplies (opens in a new tab)

December 10, 2019

Nicole Smith-Holt, Opinion

My son died from rationing insulin. Democrats’ drug pricing plan still wouldn’t help him. (opens in a new tab)

May 24, 2018

Julie Mazziotta

Mom Fights for Lower Insulin Costs After Her Diabetic Son Died from Rationing His Medication (opens in a new tab)

November 14, 2025

Activist Collective in Brazil

Insulin production in Brazil: where are we and where are we going (opens in a new tab)

November 4, 2022

Zoe Witt

https://www.teenvogue.com/story/insulin-legislation-diabetics (opens in a new tab)

July 9, 2022

Andrew Marquardt

California is single handedly trying to solve all of America’s economic problems. Next up: transforming the pharmaceutical market (opens in a new tab)

October 6, 2020

Madhukar Pai, Contributor

As We Fight The Coronavirus Pandemic, We Cannot Ignore Non-Communicable Diseases (opens in a new tab)

March 4, 2019

Weronika Strzyżyńska and Kaamil Ahmed

Eli Lilly Will Sell Half-Price Version of Humalog, Its Popular Insulin (opens in a new tab)

By creating the pressure and making the demand for affordable insulin mainstream, T1International’s work helped make [insulin affordability] an issue that couldn’t be avoided any longer.

–Dana

Democracy Collaborative

From 2024 article (opens in a new tab)

News and Statements from T1International

February 10, 2020

T1International Launches Communities of Color Campaign
January 31, 2020

T1International Statement on Brexit
January 20, 2020

#insulin4all Demonstration Outside Sanofi in Paris
June 18, 2019

T1International Releases Report on Rationing and Cost Survey Data
June 12, 2019

T1International’s Advocates Plan Canada Trip to “Birthplace of Insulin”
March 4, 2019

T1International Statement on Lilly & Novo’s ”Generic Insulin”